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Introduction
 Schizophrenia often occurs when individuals are in their late 
teens to mid-30s [1]. In many cases, schizophrenia adversely 
affects social functioning, creating considerable burdens for 
families and leading to a national-level socioeconomic impact 
[2]. Therefore, the estimation of the incidence rate of schizo-
phrenia is an important concern for national mental health 
MS#AMN 07264
Epidemiological survey of first-episode psychosis in Nagasaki, Japan: 
Is the incidence rate of schizophrenia changing?
Shinji Kanegae 1, Hideyuki naKane 2 †, Akira Imamura 3, Sumihisa Honda 4, Hirohisa KInosHIta 1, Yoshibumi naKane 5, 
Yuji oKazaKI 6, 7, Hiroki ozawa 1, 3
1 Department of Neuropsychiatry, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
2 Department of Psychiatric Rehabilitation Science, Unit of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
3 Child and Adolescent Psychiatry Community Partnership Unit, Nagasaki   University Hospital, Nagasaki, Japan
4 Department of Public Health and Nursing, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
5 Goseikai Dejima Clinic, Nagasaki, Japan
6 Koseikai Michinoo Hospital, Nagasaki, Japan
7 Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan
† The coauthor Hideyuki Nakane, who contributed substantially to the design, analysis, and interpretation of the data in this study, passed away on March 2, 2020.
 The Determinants of Outcome of Severe Mental Disorders (DOSMeD) study, a global epidemiological study led by the 
World Health Organization, reported the annual incidence rate of schizophrenia from 1979 to 1980. In 2011, approximately 30 
years later, we conducted a large-scale epidemiological study to investigate the incidence rate of first-episode schizophrenia 
in Nagasaki using the same method as the DOSMeD study. A telephone survey was conducted by researchers daily at 52 
psychiatric hospitals, clinics, and institutes in Nagasaki. When a subject was confirmed, the researcher visited the medical 
facility in person to evaluate the patient’s symptoms. Of 441,706 people in Nagasaki City, 131 people were surveyed in the 
way, resulting in the diagnosis of psychosis in 25 patients, 20 of whom were determined to have schizophrenia. These data 
were used to calculate the incidence rates of psychosis (1.00 per 10,000 population; 95% confidence interval [CI], 0.54-1.46) 
and schizophrenia (0.80 per 10,000 population; 95% CI, 0.38-1.21). The 95% CI for the incidence rate of psychosis did not 
include the incidence rate for psychosis (broad definition) reported in the DOSMeD study (2.02). However, the 95% CI for the 
incidence rate of schizophrenia did include the incidence rate for schizophrenia (restrictive definition) reported in the DOSMeD 
study (1.01). Although the incidence rate of psychosis appeared to be decreasing, no significant change was found in the 
incidence rate of schizophrenia, comparing the present findings with those of the survey conducted 30 years ago. The 
incidence rate of schizophrenia is said to vary with changes in gender differences, racial differences, urbanization, and 
immigration; we therefore considered this possibility. In the future, it is necessary to carry out longer-term surveys covering 
multiple cities using the same methods.
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planning.
 A study on the Determinants of Outcome of Severe Mental 
Disorders (DOSMeD) was conducted from 1979 to 1980. This 
collaborative survey of the incidence rate of schizophrenia 
was carried out by the World Health Organization and several 
research institutions worldwide, including the Department of 
Neuropsychiatry of Nagasaki University (Nagasaki, Japan) 
[3,4]. This survey explored the annual incidence rates of 
schizophrenia per 10,000 population in eight cities worldwide, 
reporting values ranging from 1.5 (Aarhus) to 4.2 (Chandigarh/
rural) using a broad diagnostic definition and from 0.7 (Aarhus) 
to 1.4 (Nottingham) using restrictive diagnostic criteria [3,4]. 
 The Aetiology and Ethnicity in Schizophrenia and Other 
Psychoses (AESOP) study, a large-scale, multicenter epide-
miological study of schizophrenia conducted in the United 
Kingdom, showed differences in terms of incidence rates by 
race and sex [5,6]. Regarding general incidence rates, the 
2-year AESOP survey, conducted from 1997 to 1999, indi-
cated the annual incidence rates per 10,000 population of 
psychosis and schizophrenia to be 3.5 and 1.3, respectively 
[5]. A comparison study of the AESOP data from three areas 
in 1997 and 2000 found that areas with higher numbers of 
residents of African Caribbean descent (e.g., southeast London, 
with an incidence rate of 5.5 per 10,000 person-years) had a 
significantly higher incidence rate of psychosis, compared 
with areas with lower numbers of these individuals (e.g., 
Nottingham, with an incidence rate of 2.5 per 10,000 person-
years and Bristol, with an incidence rate of 2.2 per 10,000 
person-years) [6].
 According to a meta-analysis performed on the data from 
epidemiological studies conducted from 1950 to 2009 in the 
United Kingdom, the incidence rate of psychosis (mainly 
schizophrenia) was 3.2 per 10,000 population, and the incidence 
rate of schizophrenia alone was 1.5 per 10,000 population 
[7].
 Urbanicity, sex, race, and immigration might affect the 
incidence rate of schizophrenia [8-14]. In particular, there 
have been reports of differences in schizophrenia incidence 
rates between urban and rural areas [8-11].
 Since the DOSMeD study was conducted, there have been 
no large-scale surveys on the incidence rate of schizophrenia 
in Japan. Therefore, using an epidemiological survey, this 
study aimed to assess the incidence rate of new cases of 
psychosis, especially schizophrenia, in Nagasaki, which has 
a population of approximately 440,000 (a medium-sized city 
in Japan).
Materials and methods
 This study was performed using methods submitted to and 
accepted by the Ethics Committee of Nagasaki University. 
The research plan was approved by the committee on March 
11, 2011 (approval number: 11022320).
 The study participants were patients with suspected new-
onset psychosis who visited a psychiatric hospital or clinic 
in or around Nagasaki City (Nagasaki Prefecture, Japan) 
from August 1, 2011, to July 31, 2012. The participating 
institutions were 22 psychiatric hospitals in Nagasaki City 
and its surrounding areas, including Nagasaki University 
Hospital; 28 psychiatric clinics; and 2 public organizations—
Nagasaki City Health Center and Nagasaki Prefectural Mental 
Health Welfare Center, together forming a case-finding network 
(CFN) of a total of 52 institutions. An outline of the case-
finding system is shown in Figure 1.
 The inclusion criteria for the survey were visiting one of 
these facilities for the first episode of psychosis and being 
aged 65 years or younger at the initial visit. At the initial 
visit, patients suspected of psychosis who resided in Nagasaki 
were included in the survey without restriction in terms of 
birthplace, nationality, age at onset, or family history.
 In this study, the categories of “psychosis” and “schizophrenia” 
correspond, respectively, to the “broad diagnostic definition” 
and the “restrictive diagnostic definition” used in the DOSMeD 
study. We defined psychosis using the following International 
Statistical Classification of Diseases, 10th revision (ICD-10) 
criteria [15]. In F1 disorders (mental and behavioral disorders 
caused by psychoactive substance use), psychotic disorder 
and residual and late-onset psychotic disorder caused by 
psychoactive substance use were included. In F2 disorders 
(schizophrenia, schizotypal, and delusional disorders), all 
diagnostic categories were included. In F3 disorders (mood 
[affective] disorders), manic episode, bipolar affective disorder, 
depressive episode, and recurrent depressive disorder with 
psychotic symptoms were included. In F0 disorders (organic, 
including symptomatic, mental disorders) and F7 disorders 
(mental retardation), all categories were excluded. Finally, 
states below the psychosis threshold (e.g., post-schizophrenic 
depression, residual schizophrenia, simple schizophrenia, 
precursor state, or at-risk mental state) were excluded using 
the Comprehensive Assessment of At-risk Mental States 
(CAARMS) [16]. Thus, in cases where the severity, frequency, 
or duration of symptoms was below the threshold, some 
patients included in the above categories of psychosis in the 
ICD-10 might not have been diagnosed with “psychosis” in 
this study. For the same reason, some participants diagnosed 
with schizophrenia using ICD-10 criteria might not have 
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been included in the category of “schizophrenia” in this study.
 The investigators communicated with the 52 facilities by 
phone daily except on Saturdays, Sundays, and national 
holidays. New cases of first-episode psychosis presenting on 
Saturdays or Sundays were reported on Mondays, and those 
presenting on holidays were reported on the following day. 
At each facility, designated research collaborators confirmed 
the daily information regarding new patients by evening and 
reported the information to the investigator by phone. When 
there was a suspected case of first-episode psychosis, the 
investigator visited the facility with the approval of the 
outpatient clinician and with consent from the suspected 
patient and his/her family. First, it was confirmed that this 
patient resided in Nagasaki and was younger than 65 years 
and that it was the first episode of psychosis. Informed consent 
was obtained after requesting participation, explaining the 
aim of the survey, and providing the opportunity to refuse 
participation. A detailed evaluation interview was conducted 
only for cases who met the inclusion criteria.
 For psychological assessment, the following tests were 
performed: the CAARMS to confirm that a patient was not 
below the psychosis threshold, the Positive and Negative 
Syndrome Scale (PANSS) [17] for overall symptom assessment 
including positive symptoms of schizophrenia, and the Mini-
International Neuropsychiatric Interview [18] to assess the 
presence/absence of other psychiatric disorders. All evaluations 
were conducted by SK alone, and final diagnoses, based on the 
ICD-10, were made independently by two expert psychiatrists 
(SK and AI). All diagnoses were agreed upon by these two 
researchers.
 In addition, family history, life history, pre-disease factors, 
and socioeconomic factors were evaluated using the Psychiatric 
and Personal History Schedule [3,4]. Finally, the duration of 
untreated psychosis (DUP) was investigated.
Results
Study participants
 A total of 131 cases were identified through the CFN 
during the 12-month survey period from August 1, 2011, to 
July 31, 2012. Of these cases, 29 were interviewed, and 102 
were excluded. Among the CFN facilities providing the 
cases, 78 (59.5%) were psychiatric hospitals and 53 (40.4%) 
were psychiatric clinics. In addition, regarding treatment-
 



















The investigators communicate with each Case-Finding Network (CFN) 
facilities (52 institutions: 22 psychiatric hospitals of Nagasaki and its 
surrounding areas, 28 psychiatric clinics and 2 public organizations) daily on 
weekdays. 
Report of a first-episode psychosis case by CFN 
The investigator visits the medical institution.  
An explanation of the survey is provided in a written form to a survey candidate 
and consent is obtained. 
CAARMS is performed to confirm that the state of the participant is not below 
the threshold level of psychosis.  
Evaluation of psychopathological symptoms (PANSS, M.I.N.I., etc.) 
Registration of the candidate as a study participant. 
Figure 1. The case-finding system
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based categorization, 99 cases (75.5%) were outpatients and 
32 cases (24.4%) were inpatients.
 A total of 102 cases were excluded for the following 
reasons: excluded at the stage of medical chart investigation 
because of the presence of disease conditions such as organic 
mental disorders or no obvious psychotic symptoms (n = 
73), residence outside Nagasaki (n = 9), not meeting the age 
criteria (n = 8), treatment history prior to the study period (n 
= 10), having an initial visit prior to the study period (n = 1), 
and unknown disease condition with patient visiting only for 
examination (n = 1).
 Among the 29 interviewed cases, psychosis was confirmed 
in 25. One case was below the psychosis threshold, two cases 
were excluded because the patients did not meet the geographic 
residence criteria (interviews were erroneously performed 
for non-Nagasaki residents based on misinformation), and 
one case had a treatment history at a medical institution prior 
to the study period. Figure 2 presents the course of case 
detection. 
Interviewed participants
 The characteristics of the interviewed participants are 
summarized in Table 1. The mean age was 38.8 (SD: 16.5) 
years for all individuals with psychosis (n = 25) and 38.7 
(SD: 17.1) years for those with schizophrenia (n = 20). The 
first, second, and third quartiles of participant age were 22, 
40, and 53 years, respectively, for psychosis and 22, 40.5, 
and 52 years, respectively, for schizophrenia. Figure 3. shows 
the box-and-whisker plot of age of the participants. In this 
study, the results showed the mean age of participants with 
psychosis or schizophrenia to be the late 30s.
 The male-to-female ratio was 7:18 for participants with 
psychosis and 5:15 for those with schizophrenia. The proportion 
of women was much higher than that of men in this study.
 The mean DUP for participants with psychosis was 1124 
(SD: 2216) days, whereas the mean DUP for participants with 
schizophrenia was 1151 (SD: 2323) days. The first, second, 
and third quartiles of DUP were 20.5, 60, and 512.5 days,  





















Nagasaki population: 441,706 (330,705 individuals aged between 0 and 64 years) 
The total number of cases provided by the CFN between August 1, 2011, and July 
31, 2012: 131 cases 
Interviews were conducted for 29 
cases (25 cases with psychosis, 1 case 
under the psychosis threshold, 2 
cases outside the geographic criteria, 
and 1 case with a treatment history) 
In total, 102 cases were excluded (73 
cases were excluded at the initial 
stage, 9 case patients reside outside 
Nagasaki 8 cases did not meet the age 
criteria, 10 cases had a treatment 
history, 1 case had an initial visit 
before the registration period, and 1 
case with an unknown disease 
condition) 
Psychosis onset in 25 cases: schizophrenia (n = 20), delusional disorder (n = 
2), schizoaffective disorder (n = 1), depressive episode with psychotic 
symptoms (n = 1), and psychotic disorder due to substance use (n = 1) 
Schizophrenia (n=20) 
Inclusion Exclusion 
Figure 2. The course of case detection
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respectively, for participants with psychosis and 20, 52.5, 
and 665 days, respectively, for those with schizophrenia. 
Figure 4, a box-and-whisker plot displaying the DUP for 
participants with psychosis and those with schizophrenia, 
shows that there were some outliers in both groups.
 The mean evaluation scores for the four subcategories 
(“unusual thought content,” “non-bizarre ideas,” “perceptual 
abnormalities,” and “disorganized speech”) of the CAARMS 
are shown for participants with psychosis and those with 
schizophrenia in Table 1. A simple comparison is not possible, 
but the subcategory “unusual thought content” had the highest 
score, and “disorganized speech” had the lowest score.
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Figure 3. Box-and-whisker plot of age of participants
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 The mean total PANSS score was 71.9 (SD: 18.5) for 
participants with psychosis and 73.5 (SD: 18.7) for those with 
schizophrenia. The mean scores for the three subcategories—
“Positive scale,” “Negative scale,” and “General Psychopathology 
scale”—were 23.3 (SD: 6.6), 13.4 (SD: 7.3), and 35.2 (SD: 
11.6), respectively, for participants with psychosis and 22.9 
(SD: 7.1), 14.1 (SD: 7.8), and 36.6 (SD: 9.7), respectively, 
for those with schizophrenia. These results tended to be 
higher for the positive symptom scores than for the negative 
symptom scores among both patient groups.
Incidence rate of first-episode psychosis and first-episode 
schizophrenia
　Table 2 presents the results of the survey of the incidence 
rate. As mentioned above, there were 25 first-episode psychosis 
cases, including 20 cases of schizophrenia. 
 Adjusting the population of Nagasaki (2011 population: 
441,706; population aged 0 – 64 years: 330,705) for age, the 
incidence of first-episode psychosis was 0.76 per 10,000 
persons per year, and the incidence of first-episode schizophrenia 
was estimated to be 0.60 per 10,000 persons per year.
 When participant age was set within the same range as 
that used in the DOSMeD study (15 – 54 years: 200,472 in 
2011), there were 20 cases of first-episode psychosis, including 
16 cases of schizophrenia, indicating an annual incidence 
rate of first-episode psychosis of 1.00 per 10,000 persons 
and an annual incidence rate of first-episode schizophrenia 
of 0.80 per 10,000 persons.
 Because the 95% confidence interval for the incidence 
rate of psychosis (0.54  –  1.46) did not include the incidence rate 
for the “broad diagnostic definition” reported in the DOSMeD 
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Figure 4. Box-and-whisker plot of duration of untreated psychosis (DUP)
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study (2.02) [4], the incidence rate of psychosis appeared to 
be decreasing, comparing the present findings with those of 
the study conducted 30 years ago. However, the 95% confidence 
interval for the incidence rate of schizophrenia (0.38 – 1.21) 
did include the incidence rate for the “restrictive diagnostic 
definition” reported in the DOSMeD study (1.01) [4], indicating 
no significant change in the incidence rate of schizophrenia.
Discussion
 In this study, the recent annual incidence rates of new-
onset psychosis and schizophrenia were obtained with the 
same methods used in the DOSMeD study [3.4], which was 
conducted from 1979 to 1980 in many areas around the 
world, including Nagasaki, to estimate the incidence rate of 
schizophrenia in different cultures. The present study is 
valuable because it compared the incidence rates in the same 
region after a 30-year interval.
 The results of the current study show that the incidence 
rate for the category of “psychosis” declined, compared with 
the incidence rate for the “broad diagnostic definition” reported 
in the DOSMeD study. In addition, the incidence rate for the 
category of “schizophrenia” in our study did not show any 
significant changes, compared with the incidence rate for the 
“restrictive diagnostic definition” reported in the DOSMeD 
study.
 The comparison of the present study and the DOSMeD 
study illustrated that differences in terms of diagnostic definition 
can affect the results for incidence rates. In the DOSMeD 
study, the “broad diagnostic definition” was established using 
the ICD-9 [19] diagnostic criteria for schizophrenic psychosis, 
paranoid states, part of other nonorganic psychosis, part of 
alcoholic psychoses, and part of drug psychoses, as well 
schizophrenic psychoses, paranoid psychoses, and other 
psychoses [3,4][20-23]. The DOSMeD studyʼs “restrictive 
diagnostic definition” indicated patients with schizophrenia 
exhibiting Schneiderʼs first-rank symptoms [3,4][20-23]. In 
the current study, we used the ICD-10 to determine the 
diagnostic criteria and excluded the conditions falling below 
the threshold level for psychosis using the CAARMS, which 
led to the elimination of cases categorized under the ICD-9 
criteria as latent schizophrenia, simple-type schizophrenia, 
and potentially of other conditions. Thus, because we used 
the CAARMS in this way, the broad diagnostic definition 
used in the current study was more restrictive than that used 
in the DOSMeD study, whereas the restrictive diagnostic 
definition used in the current study was similar to that used 
in the DOSMeD study. These factors were among the main 
causes of differences between the DOSMeD study and the 
current study.
 Further, changes in demographics could have affected the 
results of the present study. The total population of Nagasaki 
when the DOSMeD study was conducted was 447,444, and 
the target population of individuals aged 15 – 54 years was 
267,149 [3,4]. In 2011, when the current study was conducted, 
the total population of Nagasaki was 443,766, the target 
population of individuals aged 0 – 65 years was 330,705, and 
the population of 15 – 54-year-olds was 200,472. Thus, the 
apparent decrease in the population size of individuals in the 
target age range may have affected the results of the present 
study.
 In addition, several reports have found urbanization and 
immigration to be important factors in the incidence rate of 
psychosis [8-14], which may have affected the results of the 
current study. Nagasakiʼs population density was 1103/km2 
at the time of the DOSMeD study[3,4] and 1093/km2 at the 
time of the present study, indicating no major difference, the 
size of the younger population was smaller in 2011 than in 
1979 – 1980, and there is no evidence of progressive urbanization. 
In addition, although there is a large population outflow from 
Nagasaki, migration into the city is limited, suggesting that 
there is no change in social conditions caused by immigration. 
Thus, problems related to urbanization and immigration do 
not seem to be relevant in this case.
 Age and sex may also affect incidence rates [12,13]. Previous 
reports have shown that the incidence rate of schizophrenia 
peaks when patients are in their 20s [12]; however, in the 
present study, the mean age was 38.8 years for participants 
with psychosis and 38.7 years for those with schizophrenia, 
indicating a much later tendency in first-episode psychosis 
and schizophrenia. The male-to-female ratio of the participants 
in our study was 7:18 for participants with psychosis and 
5:15 for those with schizophrenia, indicating that there were 
more women than men. Previous studies have reported that 
the incidence rate of schizophrenia is similar in men and 
women or slightly higher in men than in women [1,24]. 
Thus, our findings are not consistent with previous work. 
This may be influenced by the fact that some young male 
patients were excluded during the recruitment phase of this 
study because they had insufficient information to support 
their diagnosis and were difficult to distinguish from patients 
with other psychiatric disorders such as neurodevelopmental 
disorders.
 There is evidence that DUP affects the severity and prognosis 
of psychosis [25-27]. In the current study, the mean DUP 
was 1124 (SD: 2216) days, and the first, second, and third 
quartiles of DUP were 20.5, 60, and 512.5 days, respectively. 
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Of the 25 cases, four remained untreated for more than 10 
years, and the high mean DUP value is attributable to these 
outliers. A 2005 study re-analyzed the participants of the 
DOSMeD study [27], reporting a mean DUP of 9.9 months, 
with first, second, and third quartiles of DUP of 1, 4, and 12 
months, respectively. Comparing the first and second quartiles 
between this 2005 study and our study shows that our findings 
for DUP were shorter.
 As mentioned above, various factors affect the incidence 
rates of schizophrenia. Several studies have shown that the 
number of individuals diagnosed with schizophrenia may 
have decreased compared with findings in previous decades. 
Söderlund et al [28]. examined 210,000 individuals living in 
Stockholm from 1955 to 1967 and showed a gradually decreasing 
number of cases with schizophrenia and other types of psychosis 
(incidence rate of schizophrenia: 4.0/10,000 in 1955 and 
1.9/10,000 in 1967). Kühl et al [29]. examined the incidence 
rate of schizophrenia and schizophrenia spectrum disorders 
from 2000 to 2012 in Denmark, finding significant decreases 
among those aged 33 years and older. In Japan, Fuse-Nagase 
et al [30]. investigated the percentage of students who took 
a leave of absence or withdrew from school because of 
schizophrenia from 1986 to 1987, from 1994 to 1995, and 
from 2013 to 2014 at 11 universities with 30,000 – 50,000 
students. They found that this percentage declined over time. 
However, another report suggested the possibility of an 
increase in the incidence rate of early-onset schizophrenia 
[31], and a systematic review and meta-analysis presented 
evidence showing that there may have been no long-term 
change in the incidence rate of psychosis [7]. Therefore, it 
cannot be clearly concluded that there have been changes in 
the worldwide incidence rate of schizophrenia. 
 The current study has several limitations. First, differences 
in the definition of “psychosis” (broad diagnostic definition) 
make a precise comparison between the present study and 
the DOSMeD study difficult. Second, some findings of our 
study, including the age at onset and the male-to-female 
ratio, are not consistent with previous studies, and it is 
possible that not all new-onset cases of psychosis occurring 
during the study period were identified.
 The results of the DOSMeD study suggested that there 
were no regional differences worldwide in the incidence rate 
of schizophrenia; however, it is currently recognized that the 
incidence rates of psychosis and schizophrenia differ 
depending on the region and environment [32,33]. In Japan, 
there has been some discussion regarding whether the 
incidence rates of new-onset psychosis and schizophrenia 
have changed or remained stable over the years [30], but this 
is the first study to present evidence showing no obvious 
change in the incidence rate of schizophrenia (restrictive 
diagnostic definition) compared with the situation about 30 
years ago.
 In future research on changes in the incidence rates of 
psychosis and schizophrenia, we will examine this rate over 
a longer period than the present 1-year investigation. It would 
also be useful to compare the incidence rates of multiple 
cities with environments that differ from that of Nagasaki in 
future work.
Acknowledgment
 This work was supported by a grant from the Ministry of 
Health, Labour and Welfare (Health and Labour Sciences 
Research Grant), Grant Number: H22-Seishin-Ippan-015.
 
References
 1. American Psychiatric Association (APA). The Diagnostic and Statistical 
Manual of Mental Disorders, Fifth Edition (DSM-5) pp102, 2013
 2. Jin H, Mosweu I. The Societal Cost of Schizophrenia: A Systematic 
Review. Pharmacoeconomics 35(1):25-42, 2017 . doi: 10.1007/s40273-
016-0444-6.
 3. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day 
R, Stromgren E, Dube KC, Leon C, Wig NN, Varma V, Walsh D, Marsella 
A, Katz M, Olatawura M, Nadzarov RA, Zharikov NN, Takahashi R, 
Nakane Y, Hanzlicek L, Gebhart J, Wynne L, Gift T. Early manifestations 
and first-contact incidence of schizophrenia in different cultures. A 
preliminary report on the initial evaluation phase of the WHO Collaborative 
Study on determinants of outcome of severe mental disorders. Psychol 
Med 16(4):909-28, 1986
 4. A.Jablensky, N.Sartorius, G.Ernberg, M.Anker, A.Korten, J.E.Cooper, 
R.Day & A.Bertelsen (E.Stromgren, K.C.Dube, C.Leon, N.N.Wig, V.
Varma, D.Walsh,A.Marsella, M.Katz, M.Olatawura, R.A.Nadzharov, 
N.N.Zharikov, R.Takahashi,Y.Nakane, L.Hanzlick, C.Skoda, L.C.Wynne 
& T.Gift): Schizophrenia :manifestations, incidence and course in 
different cultures. A World Health Organization ten-country study., 
Psychological Medicine (monographsupplement) 20, 1-97, 1992.
 5. Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, 
Lloyd T, Holloway J, Hutchinson G, Leff JP, Mallett RM, Harrison GL, 
Murray RM, Jones PB. Heterogeneity in incidence rates of schizophrenia 
and other psychotic syndromes: findings from the 3-center AeSOP 
study. Arch Gen Psychiatry 63(3):250-8, 2006
 6. Morgan C, Dazzan P, Morgan K, Jones P, Harrison G, Leff J, Murray R, 
Fearon P; AESOP study group. First episode psychosis and ethnicity: 
initial findings from the AESOP study. World Psychiatry 5(1):40-6, 
2006
 7. Kirkbride JB, Errazuriz A, Croudace TJ, Morgan C, Jackson D, Boydell 
J, Murray RM, Jones PB. Incidence of schizophrenia and other psychoses 
in England, 1950-2009: a systematic review and meta-analyses. PLoS 
One. 2012;7(3):e31660. doi: 10.1371/journal.pone.0031660. Epub 2012
 8. Szöke A, Charpeaud T, Galliot AM, Vilain J, Richard JR, Leboyer M, 
Llorca PM, Schürhoff F. Rural-urban variation in incidence of psychosis 
in France: a prospective epidemiologic study in two contrasted catchment 
areas. BMC Psychiatry 17;14:78 2014 doi: 10.1186/1471-244X-14-78.
 9. Paksarian D, Trabjerg BB, Merikangas KR, Mors O, Børglum AD, 
Hougaard DM, McGrath JJ, Pedersen CB, Mortensen PB, Agerbo E. 
109Shinji Kanegae et al.: Epidemiological survey of first-episode psychosis
The role of genetic liability in the association of urbanicity at birth and 
during upbringing with schizophrenia in Denmark. Psychol Med 48(2): 
305-314, 2018
10. Vassos E, Agerbo E, Mors O, Pedersen CB. Urban-rural differences in 
incidence rates of psychiatric disorders in Denmark. Br J Psychiatry 
208(5):435-40, 2016
11. Vassos E, Pedersen CB, Murray RM, Collier DA, Lewis CM. Meta-
analysis of the association of urbanicity with schizophrenia. Schizophr 
Bull 38(6):1118-23, 2012
12. Sutterland AL, Dieleman J, Storosum JG, Voordouw BA, Kroon J, Veldhuis 
J, Denys DA, de Haan L, Sturkenboom MC. Annual incidence rate of 
schizophrenia and schizophrenia spectrum disorders in a longitudinal 
population-based cohort study. Soc Psychiatry Psychiatr Epidemiol 
48(9):1357-65, 2013
13. Castillejos MC, Martín-Pérez C, Moreno-Küstner B. A systematic review 
and meta-analysis of the incidence of psychotic disorders: the distribution 
of rates and the influence of gender, urbanicity, immigration and socio-
economic level. Psychol Med 22:1-15, 2018
14. Schofield P, Thygesen M, Das-Munshi J, Becares L, Cantor-Graae E, 
Pedersen C, Agerbo E. Ethnic density, urbanicity and psychosis risk for 
migrant groups - A population cohort study. Schizophr Res 190:82-87, 
2017
15. World Health Organization(WHO): The ICD-10 Classification of Mental 
and Behavioural Disorders, 1993
16. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, 
Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby 
J. Mapping the onset of psychosis: the Comprehensive Assessment of 
At-Risk Mental States. Aust N Z J Psychiatry 39(11-12):964-71, 2005
17. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome 
scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261-76, 1987
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, 
Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric 
Interview (M.I.N.I.): the development and validation of a structured 
diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 
59 Suppl 20:22-33;quiz 34-57,  1998 
19. World Health Organization(WHO): International Classification Of 
Diseases - 9 - CM, (1979). http://wonder.cdc.gov/wonder/sci _ data/codes/
icd9/type _ txt/icd9cm.asp
20. Wig NN, Varma VK, Mattoo SK, Behere PB, Phookan HR, Misra AK, 
Murthy RS, Tripathi BM, Menon DK, Khandelawal SK, Bedi H. An 
incidence study of schizophrenia in India. Indian J Psychiatry 35(1):11-7, 
1993
21. Brewin J, Cantwell R, Dalkin T, Fox R, Medley I, Glazebrook C, 
Kwiecinski R, Harrison G. Incidence of schizophrenia in Nottingham. A 
comparison of two cohorts, 1978-80 and 1992-94. Br J Psychiatryx. 
171:140-4, 1997
22. Craig TJ, Siegel C, Hopper K, Lin S, Sartorius N. Outcome in schizophrenia 
and related disorders compared between developing and developed 
countries. A recursive partitioning re-analysis of the WHO DOSMeD 
data. Br J Psychiatry. 170:229-33, 1997
23. Edgerton RB, Cohen A. Culture and schizophrenia: the DOSMeD 
challenge. Br J Psychiatry 164(2):222-31, 1994  
24. Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int 
Rev Psychiatry 22(5):417-28, 2010 doi: 10.3109/09540261.2010.515205.
25. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, 
Szymanski SR. Duration of psychosis and outcome in first-episode 
schizophrenia. Am J Psychiatry 149(9):1183-8, 1992
26. Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. 
Duration of untreated psychosis as predictor of long-term outcome in 
schizophrenia: systematic review and meta-analysis. Br J Psychiatry 
205(2):88-94, 2014 
27. Kinoshita H, Nakane Y, Nakane H, Ishizaki Y, Honda S, Ohta Y, Ozawa 
H. Nagasaki schizophrenia study: influence of the duration of untreated 
psychosis on long-term outcome Acta Med Nagasaki 50: 17-22
28. Söderlund J, Wicks S, Jörgensen L, Dalman C. Comparing cohort 
incidence of schizophrenia with that of bipolar disorder and affective 
psychosis in individuals born in Stockholm County 1955-1967. Psychol 
Med 45(16):3433-9, 2015 
29. Kühl JOG, Laursen TM, Thorup A, Nordentoft M. The incidence of 
schizophrenia and schizophrenia spectrum disorders in Denmark in the 
period 2000-2012. A register-based study. Schizophr Res 176(2-3):533-
539, 2016
30. Fuse-Nagase Y, Miura J, Namura I, Sato T, Yasumi K, Marutani T, 
Sugita Y. Decline in the severity or the incidence of schizophrenia in 
Japan: A survey of university students. Asian J Psychiatr 24:120-123, 
2016
31. Okkels N, Vernal DL, Jensen SO, McGrath JJ, Nielsen RE. Changes in 
the diagnosed incidence of early onset schizophrenia over four decades. 
Acta Psychiatr Scand 127(1):62-8, 2013
32. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise 
overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67-
76, 2008 
33. van Os J, Kapur S. Schizophrenia. Lancet 374(9690):635-45, 2009
110 Shinji Kanegae et al.: Epidemiological survey of first-episode psychosis
